For the quarter ending 2025-09-30, GNTX had $61,614,583 increase in cash & cash equivalents over the period. $111,398,086 in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income from consolidated operations | 100,886,704 | 190,524,495 |
| Depreciation and amortization | 25,928,524 | 52,880,443 |
| Gain on disposal of assets | 27,925 | 133,576 |
| Loss on disposal of assets | 12,452 | 791 |
| Gain on sale of investments and technology investment income | 805,777 | 832,046 |
| Loss on sale of investments and technology investment losses | 1,467,223 | 5,163,260 |
| Reserve for credit losses | 4,778,334 | - |
| Deferred income taxes | -238,396 | -5,593,627 |
| Stock-based compensation expense related to employee stock options, employee stock purchases and restricted stock | 10,436,396 | 16,160,289 |
| Impairment charge | 2,194,148 | 6,182,000 |
| Accounts receivable, net | 9,875,241 | 20,896,565 |
| Inventories | 22,347,480 | -57,495,782 |
| Prepaid expenses and other | 9,165,685 | -2,765,009 |
| Accounts payable | 47,594,780 | 5,032,376 |
| Accrued liabilities, excluding dividends declared | -3,855,356 | 5,896,241 |
| Net cash provided by operating activities | 146,982,701 | 314,644,872 |
| Sales proceeds | 23,092,978 | 48,810,102 |
| Maturities and calls | 0 | 1,655,000 |
| Purchases | -1,064,443 | 17,331,563 |
| Plant and equipment additions | 35,584,615 | 67,834,222 |
| Proceeds from sale of plant and equipment | 14,006 | 245,105 |
| Acquisition of businesses, net of cash acquired | 12,962,753 | 143,328,862 |
| Loans to technology investment partners | 14,199,157 | - |
| Increase in other assets | -2,648,393 | 3,573,774 |
| Net cash used for investing activities | -35,926,705 | -181,358,214 |
| Issuance of common stock from stock plan transactions | 7,054,310 | 6,283,742 |
| Cash dividends paid | 26,342,323 | 54,244,161 |
| Repurchases of common stock | 30,153,400 | 198,870,165 |
| Net cash used for financing activities | -49,441,413 | -246,830,584 |
| Net decrease in cash, cash equivalents, and restricted cash | 61,614,583 | -113,543,926 |
| Cash and cash equivalents at beginning of period | 233,318,766 | - |
| Cash and cash equivalents at end of period | 181,389,423 | - |
GENTEX CORP (GNTX)
GENTEX CORP (GNTX)